Expertise in
42
conditions

Dr. Henry L. Sonneborn

Oncology
Wentworth-Douglass Hospital
789 Central Ave, 
Dover, NH 
Expertise in
42
conditions
Wentworth-Douglass Hospital
789 Central Ave, 
Dover, NH 

Overview

Henry Sonneborn is an Oncologist practicing medicine in Dover, New Hampshire.

Dr. Sonneborn is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Throat Cancer, Testicular Yolk Sac Tumor, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 2 clinical trials.

Specialties

Oncology

Licenses

Internal Medicine in NH

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
NH Healthy Families
  • EPO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Wentworth-Douglass Hospital
789 Central Ave, Dover, NH 03820

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Biological, Other
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Lenalidomide, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 2
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Drug
Study Drugs: Bortezomib, Carfilzomib, Dexamethasone, Lenalidomide
Study Phase: Phase 3
View 1 Less Clinical Trial

1 Total Publications

Dramatic Improvement of Antitranscription Intermediary Factor-1-γ/α Antibody-Positive Dermatomyositis After Stereotactic Body Radiation Therapy to Presumed Lung Primary: A Case Report.
Dramatic Improvement of Antitranscription Intermediary Factor-1-γ/α Antibody-Positive Dermatomyositis After Stereotactic Body Radiation Therapy to Presumed Lung Primary: A Case Report.
Journal: Practical radiation oncology
Published: November 10, 2019
Similar Doctors
Expertise in
15
conditions
Dr. Andrew J. Yee
Hematology | Oncology
Expertise in
15
conditions
Dr. Andrew J. Yee
Hematology | Oncology
Referral may be required

Wentworth-Douglass Hospital

789 Central Ave, 
Dover, NH 
 (0.1 miles away)
603-742-8787
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Yee is a Hematologist and an Oncologist practicing medicine in Dover, New Hampshire. Dr. Yee is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Vertebroplasty, and Bone Marrow Aspiration. Dr. Yee is currently accepting new patients.

Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

Massachusetts General Hospital

55 Fruit St, 
Boston, MA 
 (59.6 miles away)
617-724-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Abramson is currently accepting new patients.

Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required

Office

55 Fruit St, 
Boston, MA 
 (59.6 miles away)
617-724-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Edwin Choy is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Choy is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Osteosarcoma. Dr. Choy is currently accepting new patients.

Frequently Asked Questions about Dr. Henry L. Sonneborn

How do I make an appointment with Dr. Henry L. Sonneborn?

You can book an appointment with Dr. Henry L. Sonneborn by calling their office at 603-742-8787. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Henry L. Sonneborn a top-rated expert for Throat Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Henry L. Sonneborn is classified as an Distinguished expert for Throat Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Henry L. Sonneborn specialize in?

While Dr. Henry L. Sonneborn is a Oncology, they have specific expertise in Throat Cancer, Testicular Yolk Sac Tumor, and Ovarian Carcinosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Henry L. Sonneborn participate in research or clinical trials?

Yes. Dr. Henry L. Sonneborn has published 1 articles and abstracts on conditions like Throat Cancer. You can view a list of Dr. Henry L. Sonneborn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Henry L. Sonneborn accept my insurance?

Dr. Henry L. Sonneborn accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 603-742-8787 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sonneborn's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 35 Advanced Conditions
    View All 114 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile